Inhibitor Therapeutics, Inc. (INTI)

Last Closing Price: --

Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Inhibitor Therapeutics, Inc. (INTI) Cost of Goods Sold data is not available for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
--
$-3.34M
Cost of Goods Sold
--
--
$3.66M
$-3.66M
$0.32M
$-3.34M
$-3.34M
$-3.34M
$-3.34M
$-3.34M
$-3.34M
$-3.66M
$-3.66M
172.26M
172.26M
$-0.02
$-0.02
Balance Sheet Financials
$5.69M
--
--
$5.69M
$0.71M
--
$3.00M
$3.71M
$1.99M
$1.99M
$1.99M
172.32M
Cash Flow Statement Financials
$-3.23M
--
--
$8.84M
$5.61M
$-3.23M
$0.04M
--
--
Fundamental Metrics & Ratios
8.03
--
--
--
--
--
--
--
--
--
--
$-3.23M
--
--
--
--
--
--
--
-168.22%
-168.22%
-58.64%
-168.22%
$0.01
$-0.02
$-0.02